Humacyte, Inc. (HUMA)
0.4499
+0.05
(+12.31%)
USD |
NASDAQ |
Oct 27, 16:00
0.4499
0.00 (0.00%)
After-Hours: 20:00
Humacyte Market Cap : 124.98M for Oct. 27, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 26, 2026 | 111.29M |
| October 23, 2026 | 120.95M |
| October 22, 2026 | 114.76M |
| October 21, 2026 | 114.23M |
| October 20, 2026 | 112.79M |
| October 19, 2026 | 111.42M |
| October 16, 2026 | 119.18M |
| October 15, 2026 | 122.09M |
| October 14, 2026 | 98.37M |
| October 13, 2026 | 99.70M |
| October 12, 2026 | 108.23M |
| October 09, 2026 | 112.59M |
| October 08, 2026 | 124.20M |
| October 07, 2026 | 131.20M |
| October 06, 2026 | 132.79M |
| October 05, 2026 | 138.90M |
| October 02, 2026 | 144.87M |
| October 01, 2026 | 139.70M |
| September 30, 2026 | 143.82M |
| September 29, 2026 | 147.98M |
| September 28, 2026 | 152.01M |
| September 25, 2026 | 154.82M |
| September 24, 2026 | 157.98M |
| September 23, 2026 | 157.15M |
| September 22, 2026 | 161.90M |
| Date | Value |
|---|---|
| September 21, 2026 | 163.90M |
| September 18, 2026 | 162.68M |
| September 17, 2026 | 159.76M |
| September 16, 2026 | 158.34M |
| September 15, 2026 | 153.23M |
| September 14, 2026 | 155.84M |
| September 11, 2026 | 157.68M |
| September 10, 2026 | 157.54M |
| September 09, 2026 | 160.85M |
| September 08, 2026 | 165.26M |
| September 04, 2026 | 168.04M |
| September 03, 2026 | 165.57M |
| September 02, 2026 | 165.73M |
| September 01, 2026 | 158.46M |
| August 31, 2026 | 167.07M |
| August 28, 2026 | 180.60M |
| August 27, 2026 | 192.43M |
| August 26, 2026 | 189.35M |
| August 25, 2026 | 194.79M |
| August 24, 2026 | 183.96M |
| August 21, 2026 | 178.40M |
| August 20, 2026 | 189.29M |
| August 19, 2026 | 204.15M |
| August 18, 2026 | 161.60M |
| August 17, 2026 | 155.73M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 242.17B |
| Altimmune, Inc. | 396.73M |
| Protalix Biotherapeutics, Inc. | 202.64M |
| Taysha Gene Therapies, Inc. | 1.381B |
| Agenus, Inc. | 283.61M |
Market Cap Related Metrics
| PS Ratio | 41.21 |
| PEG Ratio | -0.1267 |
| Price to Book Value | 3.998 |
| Price | 0.4499 |
| Earnings Yield | -108.8% |
| PEGY Ratio | -0.1267 |